According to schedule, 2cureX’s clinical partner University Hospital Vejle today enrolled the last patient in the clinical validation study TICC1. In this interventional study, IndiTreat® test results guide the drug...
Read More
2cureX AB (“2cureX”, NASDAQ: 2CUREX) today announces that the company has established a new partnership agreement to support the commercialization of IndiTreat in Portugal and Spain. The partnership agreement will...
Read More
